In a report released yesterday, W. Andrew Carter from Stifel Nicolaus maintained a Hold rating on Tilray (TLRY – Research Report), with a price target of $1.90. The company’s shares closed yesterday at $2.53.
According to TipRanks, Andrew Carter is ranked #4057 out of 8496 analysts.
In addition to Stifel Nicolaus, Tilray also received a Hold from Piper Sandler’s Michael Lavery in a report issued on July 27. However, on the same day, TD Cowen maintained a Buy rating on Tilray (NASDAQ: TLRY).
See the top stocks recommended by analysts >>
TLRY market cap is currently $1.6B and has a P/E ratio of -0.96.
Based on the recent corporate insider activity of 36 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of TLRY in relation to earlier this year. Most recently, in June 2023, Hopkinson David G., a Director at TLRY bought 3,858.00 shares for a total of $6,095.64.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.
Read More on TLRY:
- Tilray Stock Surges 27% in 2 Days. How Much Higher Can It Go?
- Rising High: Exclusive talk with biotech company Tryp Therapeutics
- Tilray price target lowered to $2 from $3 at Piper Sandler
- Tilray price target lowered to $3 from $5 at TD Cowen
- Tilray renews distribution agreement with Great North Distributors
